2010
DOI: 10.2337/dc09-2310
|View full text |Cite|
|
Sign up to set email alerts
|

Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes

Abstract: OBJECTIVEWe examined prevalence of sarcopenia in Korean patients with type 2 diabetes and compared body compositional parameters between subjects with and without type 2 diabetes.RESEARCH DESIGN AND METHODSThe Korean Sarcopenic Obesity Study (KSOS) included 810 subjects (414 patients with diabetes and 396 control subjects) who were examined using dual-energy X-ray absorptiometry. Prevalence of sarcopenia was defined using the skeletal muscle index (SMI).RESULTSPrevalence in patients with diabetes and in the co… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

22
376
4
19

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 504 publications
(434 citation statements)
references
References 12 publications
(15 reference statements)
22
376
4
19
Order By: Relevance
“…The pathophysiology of muscle wasting in patients with chronic diseases is not entirely clear yet. Signaling pathways may be different in healthy aging and in patients with chronic diseases with higher inflammatory load and thus more pronounced proteasome activity in patients with chronic disease, thus serving as a basis for active myofibril degeneration (34,39). Indeed, one of the hypotheses holds that inflammatory processes, which accompany many chronic diseases, may lead to metabolic changes.…”
Section: Discussionmentioning
confidence: 99%
“…The pathophysiology of muscle wasting in patients with chronic diseases is not entirely clear yet. Signaling pathways may be different in healthy aging and in patients with chronic diseases with higher inflammatory load and thus more pronounced proteasome activity in patients with chronic disease, thus serving as a basis for active myofibril degeneration (34,39). Indeed, one of the hypotheses holds that inflammatory processes, which accompany many chronic diseases, may lead to metabolic changes.…”
Section: Discussionmentioning
confidence: 99%
“…Typically, people with sarcopenic obesity have visceral fat accumulation [58], a well-known risk factor for cardiovascular mortality [46]. The prevalence of sarcopenic obesity has been reported to be higher in type 2 diabetes compared with non-diabetes (15.7% vs 6.9% respectively in the Korean Sarcopenic Obesity Study) [59] and it has also been linked to an increased risk of falls [59], physical disability [60] and cardiovascular and all-cause mortality [61][62][63][64]. Another possible explanation could be reverse causation.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to the impairment of functional capacity 4 , there are other health consequences related to sarcopenic obesity. One of these effects is an increased risk of developing type 2 diabetes mellitus 5 , increased levels of triglycerides, metabolic syndrome and cardiovascular disease [6][7][8] . Many times, the cause of sarcopenia, as well as obesity, is multifactorial.…”
Section: Introductionmentioning
confidence: 99%
“…Aging is typically the major cause; however, other factors may interfere with the development of this condition. These factors may include sedentary lifestyle, low consumption and absorption of nutrients, low levels of vitamin D, use of medications that cause anorexia and smoking 2,5 . Sedentary lifestyle is an important risk factor related to weight gain and the decrease in SMM 10 .…”
Section: Introductionmentioning
confidence: 99%